MA53135A - Composés de c-mannoside utiles pour le traitement d'infections des voies urinaires - Google Patents

Composés de c-mannoside utiles pour le traitement d'infections des voies urinaires

Info

Publication number
MA53135A
MA53135A MA053135A MA53135A MA53135A MA 53135 A MA53135 A MA 53135A MA 053135 A MA053135 A MA 053135A MA 53135 A MA53135 A MA 53135A MA 53135 A MA53135 A MA 53135A
Authority
MA
Morocco
Prior art keywords
useful
treatment
urinary tract
tract infections
mannoside compounds
Prior art date
Application number
MA053135A
Other languages
English (en)
Other versions
MA53135B1 (fr
Inventor
Michael Joseph Bishop
Vincent J Colandrea
James Walter Janetka
Yuehu Li
Laurel Kathryn Mcgrane
Eugene L Stewart
Iulia Strambeanu
Katherine Louisa Widdowson
Original Assignee
Fimbrion Therapeutics Inc
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fimbrion Therapeutics Inc, Glaxosmithkline Ip Dev Ltd filed Critical Fimbrion Therapeutics Inc
Priority claimed from PCT/IB2019/055806 external-priority patent/WO2020012336A1/fr
Publication of MA53135A publication Critical patent/MA53135A/fr
Publication of MA53135B1 publication Critical patent/MA53135B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04Carbocyclic radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA53135A 2018-07-10 2019-07-08 Composés de c-mannoside utiles pour le traitement d'infections des voies urinaires MA53135B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862695993P 2018-07-10 2018-07-10
PCT/IB2019/055806 WO2020012336A1 (fr) 2018-07-10 2019-07-08 Composés de c-mannoside utiles pour le traitement d'infections des voies urinaires

Publications (2)

Publication Number Publication Date
MA53135A true MA53135A (fr) 2021-05-19
MA53135B1 MA53135B1 (fr) 2022-11-30

Family

ID=74672507

Family Applications (1)

Application Number Title Priority Date Filing Date
MA53135A MA53135B1 (fr) 2018-07-10 2019-07-08 Composés de c-mannoside utiles pour le traitement d'infections des voies urinaires

Country Status (2)

Country Link
AR (1) AR115709A1 (fr)
MA (1) MA53135B1 (fr)

Also Published As

Publication number Publication date
AR115709A1 (es) 2021-02-17
MA53135B1 (fr) 2022-11-30

Similar Documents

Publication Publication Date Title
EP3691639A4 (fr) Composés monobactames de chromane pour le traitement d'infections bactériennes
MA44083A (fr) Composés de biarylmonobactame pour le traitement d'infections bactériennes
EP3893940A4 (fr) Polythérapie pour le traitement de la dystrophie musculaire
MA49279A (fr) Compositions d'anticorps optimisées pour le traitement de troubles oculaires
EP3661493A4 (fr) Régimes thérapeutiques pour le traitement de l'hémoglobinurie paroxystique nocturne
EP3790867A4 (fr) Inhibiteurs de kdm1a pour le traitement d'une maladie
EP3737361A4 (fr) Inhibiteurs de la dihydrocéramide désaturase pour le traitement d'une maladie
EP3883554A4 (fr) Composés d'aryl-aniline et d'hétéroaryl-aniline pour le traitement de marques de naissance
EP3655404A4 (fr) Composés et leur utilisation pour le traitement d'infections microbiennes
IL279993B1 (en) Mannoside-c compounds are useful for treating urinary tract infections
EP3445352A4 (fr) Compositions pour le traitement de troubles liés à l'hyperkératose
EP3773221A4 (fr) Traitement pour l'hydrocéphalie
MA47207A (fr) Composés utiles pour le traitement de troubles du tractus digestif
EP3716966A4 (fr) Compositions d'alpha-cétoacides pour le traitement de l'hypoalbuminémie
EP3541379A4 (fr) Compositions pour le traitement de l'hypertension
MA51738A (fr) Composés pour le traitement de la douleur
EP3986409A4 (fr) Inhibiteurs de l'uridine phosphorylase (upase) pour le traitement de pathologies hépatiques
EP3612214A4 (fr) Optimisation d'enzymothérapie de remplacement pour le traitement de l'homocystinurie
EP3877402A4 (fr) Traitement combiné pour l'hypertension résistante
EP4288059A4 (fr) Composés pour le traitement de l'ataxie spinocérébelleuse de type 3
EP3866601A4 (fr) Organosilanes pour le traitement d'infections
EP3883552A4 (fr) Composés cyanoaryl-aniline pour le traitement d'affections de la peau
EP4181915A4 (fr) Compositions pour le traitement de l'obésité
EP3996729C0 (fr) Composition pour la prévention ou le traitement de la dépression ou de l'anxiété
EP3826633A4 (fr) Compositions pour le traitement de l'hypertension